Obesity influences the risk of HT, i.e., through activation of the renin–angiotensin–aldosterone (RAS) system, activation of mineralocorticoid receptors, and activation of the sympathetic nervous system (SNS) (24). The gene discussed is REN; the disease is obesity disorder.